Aetiology, diagnosis and treatment of thalassemia-associated osteoporosis of the adult
- PMID: 39760968
- DOI: 10.1007/s40618-024-02503-2
Aetiology, diagnosis and treatment of thalassemia-associated osteoporosis of the adult
Abstract
Aim: This review aims to overview factors contributing to TAO development and addresses the targeted diagnostic work-up and treatment management in adult thalassemic patients.
Results: Osteoporosis management in Thalassemia is challenging because several factors contributing to its pathogenesis should be considered and controlled starting from child- hood. A multidisciplinary approach is crucial. Evidence concerning the efficacy of available anti-osteoporosis drugs in thalassemic patients is scarce. In this scenario, clinical experience and center resources often guide the treatment choice. More efforts should be made to share knowledge in this field in order to indicate specific treatment strategies for TAO management.
Methods: We performed a literature search in Pubmed from 1992 to March 2024 using the words Thalassemia and: osteoporosis, Bisphosphonates, Denosumab, Teriparatide, Romosozumab, hormone replacement therapy, growth hormone, hypogonadism, calcium, vitamin D, bone disease, sarcopenia. The search was limited to English literature including original studies, reviews, meta-analyses, case reports.
Keywords: Fracture.; Osteoporosis; Thalassemia; Thalassemia-associated osteoporosis.
© 2024. The Author(s), under exclusive licence to Italian Society of Endocrinology (SIE).
References
-
- Ishimoto AK, Shah AA (2024) Screening and early treatment for osteoporosis: who are we missing under age 65? Maturitas 187:108044 - PubMed
-
- Taher AT, Musallam KM, Cappellini MD (2021) β-Thalassemias. Longo DL, editor. N Engl J Med.;384(8):727–43
-
- Borgna-Pignatti C, Cappellini MD, De Stefano P, Del Vecchio GC, Forni GL, Gamberini MR et al (2005) Survival and complications in Thalassemia. Ann N Y Acad Sci 1054:40–47 - PubMed
-
- Bhardwaj A, Swe KMM, Sinha NK, Osunkwo I (2016) Treatment for osteoporosis in people with ß-thalassaemia. Cochrane Database Syst Rev 3:CD010429 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical